Author's posts
Interest expense will rise 20% for most low-rated healthcare companies in 2023, Moody’s says
Interest expense will rise 20% for most low-rated healthcare companies in 2023 and the metrics would further weaken if rates continue to rise, according to a new report by Moody’s Investors Service.
To meet interoperability mandates, providers and payers should build API expertise
The recent Centers for Medicare and Medicaid Services proposed Interoperability and Patient Access proposed rule is designed to provide patients with easier, more useful access to their health information, according to Drew Ivan, chief strategy officer…
DOJ, states drop appeal of Optum and Change merger
The Department of Justice and states of Minnesota and New York have dropped their appeal of the $13.8 billion merger between Optum and Change Healthcare, according to a filing Monday in the District of Columbia Circuit Court.
The plaintiffs asked for t…
CMS issues revised guidance for independent dispute resolution process
The Centers for Medicare and Medicaid Services has issued revised guidance for the independent dispute resolution (IDR) process that is part of the No Surprises Act implementation.
Northwell selects Epic to integrate its electronic health record
Northwell Health has announced an agreement with medical records software company Epic to implement the health system’s next generation electronic health record.
Northwell said the initiative is part of an ongoing digital transformation to
provide an …
MedPAC recommendations on 2024 payment rates get mixed reaction
The Medicare Advisory Payment Commission recommends a higher-than-current-law fee-for-service payment update in 2024 for acute care hospitals and positive payment updates for clinicians paid under the physician fee schedule.
CMS releases guidance for Medicare Drug Price Negotiation Program that it expects to revise by summer
The Centers for Medicare and Medicaid Services on Wednesday released the parameters for the first year of prescription drug negotiations to lower prices in Medicare.
The negotiations will affect only Medicare Part D for the first two years, for ten dr…
Novo Nordisk is the second drug company to lower the price of insulin
Danish pharmaceutical company Novo Nordisk has announced it is lowering the U.S. list prices of several insulin products by up to 75% for people living with Type 1 and type 2 diabetes.
It becomes the second drugmaker to do so, following Eli Lilly’s an…
CMS announces 27 Part B drugs for which coinsurances may be lower starting April 1
The Centers for Medicare and Medicaid Services has announced 27 prescription drugs for which Part B beneficiary coinsurances may be lower starting April 1 through June 30.
Lower Part B coinsurance will go into effect on April 1 and will be reviewed qu…
Healthcare and technology groups support proposed interoperability and prior authorization rule
Healthcare and technology groups want Medicare Advantage plans included in the Centers for Medicare and Medicaid Services’ proposed rule to expand access to health information and improve the prior authorization process.
